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Abstract: Determination is the process in which a stem cell commits to differentiation. The 
process of how a cell goes through determination is not well understood. Determination is 
important for proper regulation of cell turn-over in tissue and maintaining the adult stem cell 
population. Deregulation of determination or differentiation can lead to diseases such as several 
forms of cancer. In this study I will be using microarrays to identify candidate genes involved in 
determination by pulse induction of mouse erythroleukemia (MEL) cells with DMSO and looking 
at gene expression changes as the cells go through the early stages of erythropoiesis.  The 
pulsed induction method I have developed to identify candidate genes is to induce cells for a 
short time (30 min, 2 hours, etc.) and allow them then to grow for the duration of their 
differentiation time (8 days).  For reference, cells were also harvested at the time when the 
inducer is removed from the media.  Results show high numbers of genes differentially 
expressed including erythropoiesis specific genes such as GATA1, globin genes and many novel 
candidate genes that have also been indicated as playing a role in the dynamic early signaling of 
erythropoiesis.  In addition, several genes showed a pendulum effect when allowed to recover, 
making these interesting candidate genes for maintaining self-renewal of the adult stem cell 
population.   
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CHAPTER I 
 
 
INTRODUCTION AND LITERATURE REVIEW 
 
 
Introduction  
Determination is the process in which a stem cell commits to differentiation. The process of how a 
cell goes through determination is not well understood. Determination is important for proper 
regulation of cell turn-over in tissues and maintaining the adult stem cell population. Deregulation 
of determination or differentiation can lead to diseases such as several forms of cancer.  
Furthermore, in order to use stem cells safely in clinical situations, such as induced pluripotent stem 
cells (IPSCs), it is critical that all elements of the differentiation and determination mechanisms are 
fully understood.  By taking somatic cells from a patient and turning them into IPSCs then 
redifferentiating them into the tissue type desired, the tissue can be placed back into the patient 
with little fear of rejection because the tissue originally came from the patent.  To further 
understand how determination is regulated, I will be focusing on erythropoiesis, which is the 
formation of red blood cells as a model system.
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Hematopoiesis  
Hematopoietic stem cells (HSCs) are multipotent adult stem cells that give rise to blood cell types 
such as erythrocytes (red blood cells). Hematopoietic stem cells are important to maintain and 
replace dead or damaged cells in the immune system, platelets for clotting of blood and 
erythrocytes for oxygen transport.  Hematopoiesis is broken up into 2 major pathways (Figure 1.1) 
the leukogenic pathway which gives rise to T-cells and B-cells and the myogenic pathway which 
gives rise to erythrocytes, platelets, macrophages and other cells associated with the immune 
system.  The hierarchy of hematopoietic stem cells can also be described using molecular markers 
(Table 1.1) (Seita and Weissman 2010).  Hematopoietic stem cells are also plastic, meaning they can 
be changed into various non-blood cell types such as adipocytes (Sera, LaRue et al. 2009), pancreatic 
cells (Minamiguchi, Ishikawa et al. 2008), endothelial cells (Elkhafif, El Baz et al. 2011), 
cardiomyocytes (Pozzobon, Bollini et al. 2010), osteochondrocytes (Dominici, Pritchard et al. 2004; 
Mehrotra, Rosol et al. 2010), liver cells (Khurana and Mukhopadhyay 2008; Sellamuthu, Manikandan 
et al. 2011) fibroblasts and myofibroblasts (Ebihara, Masuya et al. 2006).  There is still debate 
whether or not these changes happen naturally in an organism, or if the plasticity of HSCs is limited 
to the lab.   
HSCs arise in the embryo early in its development.  While the exact origin of HSCs is still unknown 
several possibilities have been suggested.  One model of HSC origin is the endothelial (Jaffredo, 
Gautier et al. 1998; Nishikawa, Nishikawa et al. 1998; Eilken 2009; Boisset, van Cappellen et al. 2010; 
Oberlin, El Hafny et al. 2010).  Cells adhering to the ventral side of the aortic endothelium of the 
embryonic compartment have primitive hematopoietic progenitors cell 
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surface markers and molecular phenotype  CD34+, CD45+, CD31+, CD38-, but do not have Lineage 
markers GATA-2+, GATA-3+, c-myb+, SCL/TAL1+, c-kit+ and flk1/KDR+ (Tavian, Coulombel et al. 
1996; Labastie, Cortés et al. 1998).  It has also been suggested that the aorta-gonad mesonephros 
(AGM) region of the embryo (Murray 1932; Robertson, Kennedy et al. 2000), is the source of 
hematopoiesis as its generation occurs between embryonic day 10.5-12.0 (E10.5-12.0) and 
enhanced activity of hematopoietic stem cells occur on E 11 (de Bruijn, Ma et al. 2002; Chen, 
Yokomizo et al. 2009; Coskun and Hirschi 2010; Taylor, Taoudi et al. 2010).  Runx1 (also known as 
AML1 or CBFA2) is first detectable on E 7.5 before circulation begins from the allantois and the 
chorion (Zeigler, Sugiyama et al. 2006) and is essential for hematopoietic development (Okuda, van 
Deursen et al. 1996; Chen, Yokomizo et al. 2009).  The placenta has also been proposed as an 
alternative or extra embryonic source for HSCs (Bárcena, Kapidzic et al. 2009; Robin, Bollerot et al. 
2009).  
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Signaling and regulation of HSCs 
Stem cells are highly regulated and the micro environment also called “niches” is important for the 
regulation of HSC (Schofield 1977; Xie and Spradling 1998).  These niches maintain control over 
functions such as cell survival, self-renewal and cell fate decisions.  A common niche for many blood 
cell types is the bone marrow.  Niches in the bone marrow provide micro environment dependent 
signaling to regulate HSCs. Most HSCs are in a quiescent state (G0/G1 phase of the cell cycle) 
(Fleming, Alpern et al. 1993). However, when the hematopoietic system is agitated it either turns on 
or shuts down regulatory pathways.  This is accomplished by signaling pathways such as SDF-1 
(CXCL12/CXCR4), bone morphogenic proteins, Mpl/Thrombopoietin (TPO), Tie2/Ang1, hedgehog, 
Notch and wingless (wnt) signaling pathways.   
It is thought fetal bone marrow requires stromal derived factor 1 (SDF1), CXCL12 and CXCR4 (Ara, 
Tokoyoda et al. 2003) to maintain HSC populations and differentiation states.  These factors 
additionally regulate HSC populations in adult bone marrow (Nagasawa, Omatsu et al. 2011).  The 
bone marrow microenvironment also promotes hematopoiesis via jagged1, jagged2, Notch 2, delta 
1, delta 4, Hes1, Hes5 and deltax (Chitteti, Cheng et al. 2010).  Notch ligands released by endothelial 
cells promote long term HSC self-renewal and hematopoiesis (Butler, Nolan et al. 2010).   
SDF-1 plays an important role in embryonic development by regulating B-cells and lymphopoiesis 
(Moepps, Braun et al. 2000; Balabanian, Lagane et al. 2005).  SDF-1 has also been shown to recruit 
endothelial progenitor cells from the bone marrow using a CXCR4-dependent mechanism suggesting 
that SDF-1 and CXCR4 play a role in vascular development (Zheng, Fu et al. 2007).  SDF-1/CXCR4 
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together promote self-renewal of HSCs and regulate attachment of HSCs to the bone marrow.  
Conversely the release of HSCs from the bone marrow requires matrix metalloproteinase 9 (MMP9) 
which releases soluble Kit-ligand (Heissig, Hattori et al. 2002).  Deletions of CXCR4 in mice cause a 
reduction in the HSC pool and increase proliferation response to HSC defections (Sugiyama, Kohara 
et al. 2006; Nie, Han et al. 2008).   
Bone morphogenic proteins (BMPs) are growth factors that is part of Transforming Growth Factor 
Bata (TGF-β) family (Hari Reddi and Reddi 2009).  BMP 4 regulates hematopoiesis lineage 
commitment from mesodermal cells in both embryonic development as well as adult HSCs in the 
bone marrow (Durand, Robin et al. 2007; Goldman, Bailey et al. 2009).  High concentrations of BMP-
2, -4 and -7 maintain human cord blood (CB) cells whereas low BMP-4 induced differentiation 
(Bhatia, Bonnet et al. 1999).   
c-Mpl receptor is a cell surface cytokine receptor that responds to Thrombopoietin (TPO).  c-Mpl 
receptor expression occurs mainly on HSCs with an increased cell surface expression in 
megakaryocytic progenitors, megakaryocytes and leukemic cells (Debili, Wendling et al. 1995).  The  
c-Mpl receptor is also expressed in bone marrow, spleen and fetal liver (Chou and Mulloy 2011).  
The c-Mpl/TPO singling cascade is responsible for maintaining HSC quiescence and self-renewal 
(Bersenev, Wu et al. 2008; Rongvaux, Willinger et al. 2011).  It has been suggested that TPO starts 
the c-Mpl signal cascade by binding to c-Mpl and causes it to form a homodimer (Geddis 2010).  The 
cascade activates the downstream JAK-STAT pathway, phosphoniositide 3 kinase (PI3K) and 
mitogenic activator protein kinases (MAPKs) (Tortolani, Johnston et al. 1995; Tagaya, Burton et al. 
1996).   
Hedgehog (Hh) signaling is a signaling pathway that plays a role in controlling embryonic and adult 
stem cell fate, and it has been suggested that Hh signaling is a negative regulator of hematopoiesis 
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(Trowbridge, Scott et al. 2006).  The Hh protein binds to the transmembrane receptor Patched (Ptc), 
which subsequently activates Smoothened (Smo).  Constitutive expression of Ptc in mice causes 
induction of cell cycling and expansion of primitive bone marrow HSCs (Trowbridge, Scott et al. 
2006).  While Smo is required for fetal HSC regulation is may be dispensable in adult HSCs (Gao, 
Graves et al. 2009; Hofmann, Stover et al. 2009).  Furthermore it has been shown Gli1, the 
downstream signal of Hh, plays a role in myeloid progenitor normal and stress proliferation and 
differentiation (Merchant, Joseph et al. 2010).   
The Notch receptors and ligands play a role in proliferation, maintain or enhance HSC self-renewal 
(Ohishi, Varnum-Finney et al. 2002), differentiation (Stier, Cheng et al. 2002; Varnum-Finney, 
Brashem-Stein et al. 2003) and cell fate decisions of many cell types including HSCs (Artavanis-
Tsakonas, Rand et al. 1999; Lin and Hankenson 2011).  Notch has four receptors notch 1-4 and, five 
ligands, jagged 1 and 2 and delta like 1, 3 and 4 (Ranganathan, Weaver et al. 2011).  Notch signaling 
can respond to intrinsic and extrinsic cues (Artavanis-Tsakonas, Rand et al. 1999).  It has been shown 
in zebrafish embryos that the upstream transcription factor Hey2 was essential for HSC 
differentiation.  When Hey2 was knocked down, HSC differentiation was rescued by activation of 
Notch signaling (Rowlinson and Gering 2010).  It has also been shown that up-regulation of Notch 
and its ligands (Notch 2, Deltex, Jagged 1 and 2 and Delta 1 and 4) promote repopulation and 
maintenance of osteoblasts in vitro (Chitteti, Cheng et al. 2010).  However, some studies suggest 
notch is not required for adult HSCs self-renewal or differentiation (Mancini, Mantei et al. 2005; 
Maillard, Koch et al. 2008).  This may only apply to a subset of notch signaling (Notch1 and Jagged1)  
Wingless (Wnt) signaling plays a role in cell fate determination of various cell types including HSCs.  
Wnt and Notch signaling are involved in cross talk (Clements, Kim et al. 2011), which may provide 
greater control over self-renewal and cell fate determination.  Canonical Wnt signaling is involved in 
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ESC self-renewal (Sato, Meijer et al. 2003) and HSC differentiation (Woll, Morris et al. 2008; Deng, 
Zhuang et al. 2013).  Conversely, the non-canonical Wnt  promotes HSC self-renewal (Fleming, 
Janzen et al. 2008; Kim, Kang et al. 2009).  The canonical Wnt signaling pathway interacts with 
Frazzled (Fz) receptor and co-receptor LDL receptor related proteins 5 and 6 (LDR 5 and 6) (Wu and 
Nusse 2002).  The typical genes activated downstream are FGF20, DKK1 (Chamorro, Schwartz et al. 
2005), WISP1 (Pennica, Swanson et al. 1998), MYC (He, Sparks et al. 1998) and cyclin D1 (Tetsu and 
McCormick 1999).  In the non-canonical Wnt signaling pathway Wnt ligand Wnt3a binds to Fz but 
has a different downstream effect.  The non-canonical pathway causes an increase in intracellular 
Ca
2+
 activating protein kinase C and calmodulin (Miller, Hocking et al. 1999).  The non-canonical Wnt 
pathway overlaps Notch by stimulating the expressing of Jagged1 in bone marrow thus promoting 
self-renewal (Kim, Kang et al. 2009) 
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Erythropoiesis 
Erythropoiesis is formation of erythrocytes or red blood cells (RBCs) (Figure 1.2).  In differentiation 
some cells such as myoblasts arrest in G1 (Alemá and Tató 1987; Alema and Tatò 1994) whereas 
other fibroblasts divide after differentiation begins (Roby, Brumbaugh et al. 1977).  While 
erythropoiesis goes through several divisions (3-4) during differentiation (von Lindern 2006).  
However, the cells can forgo some of the later divisions (Sankaran, Ludwig et al. 2012).  During 
erythropoiesis, the cell alters its cell cycle shortening the G1 phase from 11 h to 5 h after an initial 
lag period of 12 h where the cells do not divide (Dolznig, Bartunek et al. 1995; Dolznig, Boulmé et al. 
2001; von Lindern, Deiner et al. 2001).  While differentiating in cell culture as proerythroblasts, cells 
synchronize when induced during the initial 12 h lag phase shortening the doubling time from 24 
hour to 12 hours (Dolznig, Boulmé et al. 2001).  During differentiation, a shortened cell cycle is 
required for normal-sized erythrocytes to form.  The transcription factor E2f4 plays a role in the 
differentiation cell cycle but not the normal self-renewal cell cycle (von Lindern 2006).  However, 
E2F4-/- mice are not anemic, suggesting that cell divisions do not affect molecular processes other 
than controlling cell size (Grebien, Dolznig et al. 2005).  The switch to differentiation cell cycles is 
marked by changes in several cell cycle regulators such as cyclin D1 down-regulation and cdk4/cdk6, 
Cip1 and Kip1 (Murray 1932; Dolznig, Bartunek et al. 1995; Ciemerych, Kenney et al. 2002; 
Malumbres, Sotillo et al. 2004).  Within hematopoiesis some changes are specific to erythropoiesis, 
include globin synthesis, increase in blood antigens and an enrichment in cation transporters 
(Novershtern, Subramanian et al. 2011). 
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Like in many hematopoietic progenitor cells, many signaling pathways regulate erythropoiesis.  One 
cytokine that play a role in erythropoiesis is Stem Cell Factor (SCF) which is a c-kit ligand and 
promotes self-renewal of erythropoiesis and progenitor stem cells (Huang, Nocka et al. 1990; Zsebo, 
Williams et al. 1990).  p53, ERK and Bcl2/Bcl-XL along with SCF stimulate erythroblast proliferation 
(Kapur, Chandra et al. 2002; Zeuner, Pedini et al. 2003).  Notch signaling also inhibits erythropoiesis 
and promotes self-renewal of progenitor cells (Ishiko, Matsumura et al. 2005; Tachikawa, 
Matsushima et al. 2006; Henning, Schroeder et al. 2007).  Notch and SCF work together to maintain 
homeostasis of erythrocytes (Robert-Moreno, Espinosa et al. 2007; Zeuner, Francescangeli et al. 
2010).   
Once the decision is made to differentiate, erythroid progenitor cells go through the following 
stages, erythroid burst forming unit (BFU-E), erythroid colony forming unit (CFU-E), proerythroblast, 
basophilic erythroblast, polychromatic erythroblast, orthochromatic erythroblast, reticulocyte and 
erythrocyte (Ogawa 1993).   
BFU-Es are the first cells committed to the Erythroid lineage and form large clustered burst colonies 
on semisolid media (Heath, Axelrad et al. 1976).  BFU-Es make up approximately 0.03% of bone 
marrow hematopoietic cells with only about 40% of the population active (Iscove 1977).  BFU-Es 
require interleukin 3 (IL-3) or granulocyte macrophage colony stimulating factor (Sawada, Krantz et 
al. 1990) as well as Stem Cell Factor (SCF) but no accessory cells are required for self-renewal (Dai, 
Krantz et al. 1991).  However BFU-E have a limited response to erythropoietin (Epo) due to a 
reduced expression of Epo receptor on the cell surface (Sawada, Krantz et al. 1990).   
CFU-Es like BFU-E form colonies on semisolid media but the colonies are much smaller (Heath, 
Axelrad et al. 1976).  CFU-E make up approximately 0.3% of the bone marrow hematopoietic cell 
population and nearly all CFU-E cells are active (Iscove, Sieber et al. 1974).  CFU-Es divide rapidly 
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with an average doubling time of about 7 hours (Nijhof and Wierenga 1983).  However CFU-Es, 
unlike BFU-Es, respond to erythropoietin and insulin like growth factor 1 (IGF-1) (Noguchi, Fukumoto 
et al. 1988; Dai, Krantz et al. 1991).  CFU-Es resemble proerythroblasts with a size of about 16-20 
µm, a large nucleus, irregular chromatin (not much condensed chromatin), basophilic cytoplasm, 
large mitochondria and a cytoplasm packed with ribosomes (Nijhof and Wierenga 1983) .  Late stage 
CFU-Es may begin to synthesize  hemoglobin (Heath, Axelrad et al. 1976).   
The remaining steps in erythropoiesis cause progressive decreases in cell size and a shift from 
basophilic to acidophilic cytoplasm do to the accumulation of hemoglobin and loss of organelles 
(Orlic, Gordon et al. 1965).  Proerythroblasts, like CFU-Es, have a large nucleus but with more 
condensed chromatin and fewer mitochondria (Nijhof and Wierenga 1983).  Proerythroblasts have a 
large diameter of 15-20 µm (Panzenböck, Bartunek et al. 1998).   
Basophilic erythroblasts have a diameter of 12 to 18 µm with a large nucleus and more condensed 
DNA then a Proerythroblast (Orlic, Gordon et al. 1965; Panzenböck, Bartunek et al. 1998).   
Polychromatic erythroblasts have a wide range of cell size corresponding with the number of 
divisions and a smaller nucleus (Panzenböck, Bartunek et al. 1998).   
Orthochromatic erythroblasts are about the size of a mature erythrocyte with an acidophilic 
cytoplasm that is devoid of organelles except for the rare mitochondria, large amount of 
hemoglobin and fewer free ribosomes (Orlic, Gordon et al. 1965; Panzenböck, Bartunek et al. 1998).  
Also orthochromatic erythroblasts have a definite loss of self-renewal potential (Tarbutt and Cole 
1970).    
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Reticulocytes undergo enucleation, however reticulocytes still have RNA in the cell, although much 
is degraded and the cells contain few ribosomes (Koury, Koury et al. 2005).  Some reticulocytes stay 
in the bone marrow until they become mature erythrocytes.   
Erythrocytes start to leave the bone marrow at the end of the reticulocyte stage and early mature 
erythrocyte state.  Erythrocytes have a small diameter 7-8 µm with a flat donut shaped membrane 
for increased surface area and an accumulation of heme causing the red color (Panzenböck, 
Bartunek et al. 1998).   
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Activators and regulators of erythropoiesis  
Cytokines are important for regulating erythropoiesis, the cytokines thrombopoietin (TPO), IL-3, IL-6, 
IL-8, IL-9 and IL-11act to increase the number of BUF-Es (Birkmann, Oez et al. 1997).  While TPO and 
the interleukin cytokines are not required for erythropoiesis Stem Cell Factor (SCF) and 
erythropoietin, (EPO) and their receptors c-kit and Epo-R respectively are required for maintenance 
of some erythropoiesis progenitors (Russell 1979).   
EPO  and SCF dependent cells can be isolated from CD34+ peripheral stem cells and bone marrow 
(Panzenböck, Bartunek et al. 1998).  EPO and SCF promote growth of erythroid progenitors in vitro 
(Muta, Krantz et al. 1994).  Alternatively transforming growth factor alpha or steroid hormones in 
combination with EPO can stimulate self-renewal of some erythroid progenitors (Schroeder, Gibson 
et al. 1993).  SCF is a c-kit ligand that promotes proliferation in embryonic and committed stem cell 
progenitors (Broudy 1997).  However c-Kit expression is only high in early erythroid progenitors, 
such as BFU-Es and CFU-E sand expression drops off completely by the orthochromatic stage 
(Broudy 1997).   
EPO is a 34 KD glycoprotein that stimulates proliferation, differentiation and survival of erythroid 
progenitors (Krantz 1991).  EPO is primarily produced in the kidney and to a lesser extent in the liver.  
EPO travels through the blood and binds to the erythropoietin receptor (EPO-R) in erythroid 
progenitor cells.  EPO-R is part of the type 1 cytokine receptor superfamily lacking any kinase 
domain (Bazan 1990).  Upon binding of EPO to the EPO-R it forms a homodimer; then the tyrosine 
kinase JAK2 phosphorylates the EPO-R and recruits STAT5a/b, SHP1, SHP2, SHIP, p85 and PI-3 kinase 
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to propagate the signal (Witthuhn, Quelle et al. 1993; Richmond, Chohan et al. 2005).  EPO can 
regulate cell survival and can also regulate cell cycle genes (Fang, Menon et al. 2007; 
Sathyanarayana, Dev et al. 2008).  EPO downstream signals PI3K/Akt regulate cyclin D3 E and A, as 
well as p27
Kip1
 at the protein level (Sivertsen, Hystad et al. 2006).  Protein kinase B (PKB) and Akt also 
regulate important genes in proliferation and cell survival such as Fox03a and FKHR-L1 at the 
transcript level (Brunet, Bonni et al. 1999; Kashii, Uchida et al. 2000; Bakker, Blázquez-Domingo et 
al. 2004).  Not only can Akt promote survival and proliferation but Akt can also promote 
differentiation complementing EPO-R signaling in a JAK2 and IP-3 independent manor (Ghaffari, 
Kitidis et al. 2006).  Akt may modulate differentiation through phosphorylation of GATA-1 (Kadri, 
Maouche-Chretien et al. 2005).   
GATA-1 and GATA-2 are the 2 members of the GATA family of transcription factors that are involved 
in differentiation of erythrocytes (Shimizu and Yamamoto 2005).  GATA-2 expression is higher in 
early erythroid and other hematopoietic lineages, whereas GATA-1 expression is found in later 
stages of the erythroid linages (Weiss, Keller et al. 1994; Fujiwara, Chang et al. 2004).  While 
expression of the two transcription factors overlap they also negatively regulate each other on the 
transcriptional level (Grass, Boyer et al. 2003).   
Regulation of GATA-1 is tightly controlled in erythropoiesis.  GATA-1
-/-
 mice die at day 10-12 after 
fertilization with cells arrested at the proerythroblast stage (Keller 1995).  Acetylation and 
phosphorylation also regulate GATA-1’s activity (Lamonica, Vakoc et al. 2006).  Akt phosphorylates 
GATA-1 at S310 causing an increase in transcriptional activity of GATA-1 targets (Zhao, Kitidis et al. 
2006).  GATA-1 is also regulated by direct protein-protein interactions with PU.1 (Rekhtman, 
Radparvar et al. 1999).  GATA-1 can also be enhanced by other interacting proteins like Friend of 
GATA-1 (FOG-1) (Cantor and Orkin 2005).   
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Micro RNAs (miRNAs) have been implicated in playing a role in many cellular processes including 
erythropoiesis.  Ago2 is a protein involved in the dicer complex used for gene silencing, and Ago2-/- 
mice had erythropoiesis arrested with an abundance of basophilic erythroblasts in the bone marrow 
indicating that miRNA play a critical role in the progression of erythropoiesis (O’Carroll, 
Mecklenbrauker et al. 2007).  When miR-221 and miR-222 are overexpressed in Erythroid progenitor 
cells, erythropoiesis is blocked, identifying these miRNAs as playing a role in erythropoiesis (Felli, 
Fontana et al. 2005).  Conversely miR-210 and miR- 451 have been implicated in promoting 
erythropoiesis (Masaki, Ohtsuka et al. 2007; Kosaka, Sugiura et al. 2008) showing a diverse role of 
miRNA in the regulation of erythropoiesis.   
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Mouse Erythroleukemia (MEL) cells 
MEL cells are virally transformed cells that are maintained at the proerythroblast state by the 
Friend spleen focus-forming virus (SFFV).  This retrovirus integrated into the genome at the Spi1 
locus (Moreau-Gachelin, Tavitian et al. 1988).  This caused high expression of the PU.1 
transcription factor leading to dephosphorylation of SATA-1 by SHP-1, which is believed to 
responsible for the arrest in differentiation (Schuetze, Paul et al. 1992).  Furthermore PU.1 may 
also form a complex with histone deacetylase 1 to repress the expression of c-myc (Kihara-
Negishi, Yamamoto et al. 2001).  MEL cells can be induced to differentiate into erythrocytes by 
treating with a polar planer solvent, such as DMSO (Friend, Scher et al. 1971).   
MEL cells have been shown to have “memory”.  MEL cells have a lag period of approximately 12 
hours when induced, but when the inducer is removed and added back later the cells do not go 
through the lag phase again (Levenson and Housman 1979).  The “memory” of MEL cells lasts 
anywhere from 18 to 72 hours.  Furthermore the commitment is independent of what inducer is 
used.  Changing the inducers partway through differentiation has no effect when compared to 
cells treated with only one inducer for the same amount of time (Housman, Gusella et al. 1978).  
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Figure 1.1: Diagram of hematopoiesis, starting with a hematopoietic stem cell (HSC)
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Cell type Markers 
HSC Lin
-
 CD133
+
 CD34
+ 
Common myeloid progenitor  CD34
+
 CD38
+
 CD45RA
-
 IL-3Ralpha
+ 
Common lymphoid progenitor CD34
+
 CD38
+
 CD10
+
 
Erythrocyte CD34- CD71- GylA+ 
Mast cell CD3
-
 CD14
-
 CD16
-
 CD19
-
 CD56
-
 HLA DR
+
 
Megakaryocyte CD34- CD41+ CD61+ CD45-  
Basophil CD22+ CD123+ CD33+/- CD45dim 
Neutrophil CD16
+
 CD11b
+
 
Eosinophil IL-3Ralpha
+
 CD33
dim
 
Monocyte CD14
+
 CD45
dim
 
B lymphocyte CD19
+
 CD27
+/-
 IgD
+/-
 
T lymphocyte CD8/CD4
+
 CD61L
+/-
 CD45Ra
+/-
 
NK cells CD56+
/-
 CD14
-
 CD19
-
 CD16
+/-
 CD3
+/-
 CD1d
+
 
Table 1.1: Markers for cell types found in the hematopoietic linage.   
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Figure 1.2: Erythropoiesis: the first committed cell in the Erythroid linage is the burst forming 
unit erythroblast (BFU-E).  BUF-E differentiates into a colony forming unit erythroblast (CFU-E).  
As the cells continue to differentiate through proerythroblasts to orthochromatic erythroblasts 
the cells shrink in size, DNA condenses in the nucleus and the cytoplasm becomes more acidic 
do to the accumulation of hemoglobin.  During the reticulocyte stage the cells become 
enucleated and as the cells become mature erythrocytes they leave the bone marrow and enter 
blood vesicles.    
19 
 
CHAPTER II 
 
 
METHODOLOGY 
 
 
Competent DH5-alpha E. coli cells  
Competent DH5-alpha E. coli cells were made by picking a single colony from an LB (10g 
tryptone, 5g yeast extract and 10g NaCl in 1 L diH2O, pH 7.0) agar plate and growing in 5 ml LB 
broth overnight.  1 ml of LB culture was added to 250 ml SOB (20g tryptone 5g yeast extract, 2 
ml 5M NaCl, 2.5 ml 1M KCl, 10 ml 1M MgCl2, 10 ml 1M MgSO4 in 1 L diH2O, pH 7.0) broth 
and grown at 18°C to an OD of 0.600.  The cells were then centrifuged at 2,500 x g at 4°C for 10 
min and the pellet was washed and  resuspended in 10 ml ice cold TB(10 mM PIPES, 15 mM 
CaCl2, 250 mM KCl, 55 mM MnCl2, in 250 ml H2O, pH 6.7).  1.4 ml of DMSO was added and 
incubated on ice for 10 min.  0.5 ml aliquots were stored in pre-chilled tubes at -80°C for later 
use. 
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Degenerate PCR 
The promoter was amplified using 2 μl of 10 mM of each primer, using 10 ng pHippy (Kaykas 
and Moon 2004) as a template in 20 μl diH2O and 25 μl 2x master mix (5 μl Taq Polymerase 5 
U/μl, 60 μl of MgCl2 25 mM 6 μl of 100 mM dNTP, 100 μl of 10x PCR buffer, and 329 μl 
diH2O).  The PCR reaction was pre heated to 94°C for 2 min.  The reaction first went through 9 
less stringent cycles to allow the degenerate primers to bind. These cycles were denaturing at 
94°C for 20 sec, annealing at 60°C for 45 sec and elongation at 72°C for 4 min.  Subsequent 
amplification continued for 19 more cycles at more stringent conditions; denaturing at 94°C for 
20 sec, annealing at 55°C for 45 sec and elongation at 72°C for 4 min.  A final elongation step of 
72°C for 7 min was added to ensure that any fragments were completely amplified.   
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Plasmid Preparation 
10 μl of the ligation reaction were added to 0.1 ml competent DH5-alpha cells prepared as 
described above and incubated on ice for 30 min.   The mixture was then placed in a 42°C heat 
block for 45 sec and returned to ice for 2 min.  The cells were then allowed to recover in low salt 
LB for 1 hour at 37°C with vigorous shaking.  0.1 ml of recovered cells was added to a low salt 
LB + Zeocin (Invitrogen Cat. No. R250-01) at 100 μg/ml plate. The plated cells were grown over 
night at 37°C.  To identify transformants the next day 4-10 colonies were picked and put in 5 ml 
low salt LB + Zeocin (100 μg/ml broth) and grown overnight at 37°C.  The cells were centrifuged 
at 2,000 x g for 10 min at 4°C.  The pellet was resuspended in 200 μl ice cold solution 1 (50 mM 
glucose, 25 mM Tris HCl, 10 mM EDTA) by vortexing.  400 μl of fresh solution 2 (930 μl 
diH2O, 20 μl 10 M NaOH, 50 μl 20% SDS) was added and mixed by inverting the tube.  The 
tubes were then put on ice.  300 μl of ice cold solution 3 (294 g potassium acetate, 50 ml glacial 
acetic acid filled to 1 L with diH2O) was added and tubes were incubated on ice for 5 min.  The 
tubes were then centrifuged at 16,000 x g for 5 min at room temperature.  600 μl of supernatant 
was transferred to a fresh microfuge tube and 600 μl isopropanol was added.  The tubes were 
mixed by inverting and incubated at -20°C for 1 hour.  The DNA was then centrifuged at 16,000 
x g for 5 min at room temperature.  The supernatant was removed and the DNA pellet was 
washed with 1 ml of 70% ethanol then centrifuged at 16,000 x g for 5 min at room temperature.  
The supernatant was removed and the DNA pellet was air dried for 1 hour.  The DNA pellet was 
then resuspended in 100 μl of 0.1 X TE. RNA was then removed by adding 1 μl of 20 mg/ml 
RNAse A (Invitrogen Cat. No. 12091-04) and incubated at 42°C for 15 min.  The DNA was 
purified using DNA spin columns (Qiagen Cat. No. 28004).  
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Construction of pHIP-HUT-TR  
The vector pHIP-HUT-TR (Figure 2.2 B) was designed using pHippy (Figure 2.2 C. Graciously 
provided by Dr. Moon) (Kaykas and Moon 2004) which is a bi-directional siRNA producing 
vector using the human U6 and H1 RNA polymerase 3 promoters.  Using degenerate primers 
(Table 2.2.1) containing a TetR binding site overlapping the TATA box, the promoters were 
amplified and modified using PCR.   
The U6 promoter was amplified to make U6TetO using 2 μl of 10 mM primers U6 UP and U6 DN, 
using 10 ng pHippy as a template in 20 μl diH2O and 25 μl 2x master mix.  Degenerate primer 
amplification was the same as described above.    
5 μl of the U6TetO PCR fragment 500 ng/μl and 5 μl of pHippy 480 ng/μl were cleaved using 
restriction enzymes (New England BioLabs Inc.) NheI (1 μl at10 U/μl) and (MluI 1 μl at10 U/μl) 
in 2 μl 10x NEBuffer 2 and 11 μl diH2O (total volume 20 μl). The mixture was incubated at 37°C 
overnight.  The pHippy fragments were treated with calf alkaline phosphatase (1 μl at 1U/μl, 
Promega) for 30 min at 42°C and both fragments were purified using gel extraction by cutting out 
the 1.8 kb fragment from a 1% agarose gel run in TAE and dissolving the gel slice in 3x volume 
buffer QG (Qiagen) and isolating the DNA on a DNA spin columns (Qiagen Cat. No. 28004).  1 
mg of U6TetO and 400 ng of pHippy–U6 fragments were ligated using 1 μl T4 DNA ligase at 400 
U/μl (New England BioLabs Inc), 4 μl of 5x T4 DNA ligase buffer and 8 μl diH2O (total volume 
20 μl) and incubated overnight at room temperature. 
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10 μl of the pHippy–U6/U6TetO ligation reaction were added to 0.1 ml competent DH5-alpha cells 
and incubated on ice for 30 min.  The plasmids were transfected into the competent cells as 
described above.   
The sequence of pHIP-UT (pHIPpy-U6TetO) was confirmed by Sanger di-deoxy sequencing at the 
Oklahoma State University Recombinant DNA/Protein Resource Facility.   
The H1 promoter was amplified to make H1TetO using 2 μl of 10 mM primers “H1 UP” and “H1 
DN”, using 10 ng of pHippy as a template in 20 μl diH2O and 25 μl 2x master mix.  The PCR 
reaction was pre heated to 94°C for 2 min.  Degenerate primer amplification was the same as 
described above.    
Due to the inverted repeat of the TetR binding site being proximal to the restriction enzyme 
binding site, the digestion or ligation of H1TetO was ineffective, thus an alternative approach of 
sewing PCR was used.  Two μl of 10 mM primers H1 UP reverse complement shift (H1 UP RC 
Shift) and U6 DN, using 10 ng pHIP-UT as a template in 20 μl diH2O and 25 μl 2x master mix.  
Degenerate primer amplification was the same as described above.   
 Sewing, also called joining PCR (Yon and Fried 1989), was used to combine the H1 RC shift 
and H1TetO PCR fragments (Figure 2.3).  The fragments are joined together based on overlapping 
regions that act as primers and templates for the other fragments.  One mg of the H1 RC Shift and 
H1TetO fragments were amplified in 21 μl diH2O and 25 μl 2x master mix.  The PCR reaction was 
preheated to 94°C for 2 min.  The reaction first went through 29 cycles consisting of denaturing 
at 94°C for 20 sec, annealing at 55°C for 45 sec and elongation at 72°C for 4 min.  A final 
elongation step of 72°C for 7 min was added to ensure that all fragments were completely 
amplified.  
5 μl of the sewing PCR fragment 500 ng/μl and 5 μl of pHippy 480 ng/μl were cleaved using 1 μl 
NotI at10 U/μl and 1 μl MluI at10 U/μl restriction enzymes (New England BioLabs Inc.) in 2 μl 
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10x NEBuffer 2 and 11 μl diH2O (total volume 20 μl) which were incubated at 37°C overnight.  
The pHippy fragment was then treated with 1 μl calf alkaline phosphatase at 1U/μl (Promega) for 
30 min at 42°C. Both fragments were purified using gel extraction by cutting out the 450 bp 
(sewing) and 1.7 kb (pHippy) fragments from a 1% agarose gel and dissolving the gel slice in 3x 
volume buffer QG (Qiagen) and isolating the DNA on a DNA spin column (Qiagen Cat. No. 
28004).  600 ng of sewing PCR fragment (Figure 2.2 A) and 600 ng pHippy–U6/-H1 fragments were 
ligated in 1 μl T4 DNA ligase 400 at U/μl (New England BioLabs Inc.), 4 μl 5x T4 DNA ligase 
buffer and 9 μl diH2O (total volume 20 μl) and incubated overnight at room temperature.   
10 μl of the pHippy–U6/-H1/sewing PCR fragment ligation reaction were added to 0.1 ml competent 
DH5-alpha cells and incubated on ice for 30 min.  The plasmids were transfected into the 
competent cells as described above.   
The sequence of pHIP-HUT (pHIPpy-H1TetO-U6TetO) was confirmed by Sanger di-deoxy 
sequencing at the Oklahoma State University Recombinant DNA/Protein Resource Facility.   
The tet repressor (Yang, Zubay et al. 1976) was inserted into pHIP-HUT by first isolating it from 
pCDNA6-TR.  1 mg of pCDNA6-TR and 1 mg of pHIP-HUT were cleaved using 1 μl MluI at 10 
U/μl restriction enzyme (New England BioLabs Inc.) in 2 μl 10x NEBuffer (total volume 20 μl) 
then were incubated at 37°C overnight.  The pHIP-HUT digest was then treated with 1 μl calf 
alkaline phosphatase 1U/μl (Promega) for 30 min at 42°C.  The pHIP-HUT 2.1 kb fragment 
(Figure 2.2A) and the 2.4 kb tet repressor fragment were isolated and purified as described 
previously. 500 ng of tet repressor and 500 ng of pHIP-HUT fragments were ligated in 1 μl T4 
DNA ligase 400 U/μl (New England BioLabs Inc.), 4 μl 5x T4 DNA ligase buffer and 8 μl 
nanopure filtered H2O (total volume 20 μl) and incubated overnight at room temperature.   
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10 μl of pHIP-HUT/tet repressor ligation reaction were added to 0.1 ml competent DH5-alpha 
cells and incubated on ice for 30 min.  The plasmids were transfected into the competent cells as 
described above.   
The sequence of pHIP-HUT-TR was confirmed by Sanger di-deoxy sequencing at the Oklahoma 
State University Recombinant DNA/Protein Resource Facility.   
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MDA-MB-231 cells 
MDA-MB_231/GFP-RFP cells (Cell BioLabs Inc. Cat. No. AKR-221) were grown in a T-25 
flask with high glucose DMEM (HyClone Cat. No. SH30081.01) 10% fetal bovine serum (FBS) 
(Promega Cat. No. S11550) 0.1 mM non-essential amino acids (NEAA) (BioWhittaker Cat. No. 
13-114E) 2% Pen/Strep (Cellgro Cat. No. 30-002-C2) and 2 mM L-glutamine at 37°C and 5% 
CO2.   
MDA-MB-231 cells were passaged at 70-95% confluence by removing the media and adding 1 
ml of 1x Trypsin EDTA (Cellgro Cat. No. 23-452-C1) at 37°C for 1 min while gently shaking by 
hand.  Trypsonization was halted by adding 10 ml of growth media and the cells were removed to 
a centrifuge tube. The cells were centrifuged at 200 x g for 5 min, resuspended in 10 ml of fresh 
growth media and placed back into fresh T-25 flasks. 
Frozen stocks  of MDA-MB-231 cells were made by placing 0.8 ml of 106-107 cells/ml from 
growth media into cryovials, then adding 0.1 ml FBS and 0.1 ml DMSO followed by placing the 
cells in an isopropanol bath in a -80°C freezer overnight.  The next day the cryovials were 
transferred into a liquid nitrogen tank for long term storage.   
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Mouse Erythroleukemia (MEL) cells 
MEL cells (graciously provided by Dr. Robert Matts, Oklahoma State University) were grown in 
T-25 flasks with high glucose DMEM (HyClone Cat. No. SH30081.01), 10% fetal bovine serum 
(FBS) (Promega Cat. No. S11550), 0.1 mM non-essential amino acids (NEAA) (BioWhittaker 
Cat. No. 13-114E), and 2% Pen/Strep (Cellgro Cat. No. 30-002-C2) at 37°C and 5% CO2.   
MEL cells were passaged at 60-80% confluence by removing a 1 ml aliquot of cells and adding 9 
ml of growth media to the aliquot to a new T-25 flask.  
Frozen stocks  of MEL cells were made by placing 0.8 ml of 106 cells/ml from growth media into 
cryovials, then adding 0.1 ml FBS and 0.1 ml DMSO followed by placing the cells in an 
isopropanol bath in a -80°C freezer overnight.  The next day the cryovials were transferred into a 
liquid nitrogen tank for long term storage.   
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Validating pHIP-HUT-TR  
siRNAs (Table 2.2) were designed by taking 20-24 nt sequences from copepoud Pontellina 
plumata ppluGFP2 copGFP (Shagin, Barsova et al. 2004) DNA sequence (Cell Biolabs Inc.) and 
aligned using BLASTn with the human genome.  3 sequences with < 100% matches and the 
reverse complement were designed with an extruding d(A)4 tail at the 5’ end. 
600 ng of pHIP-HUT-TR was cleaved using 1 μl BsmBI at10 U/μl restriction enzyme (New 
England BioLabs Inc.) in 2 μl 10x NEBuffer 3 and 11 μl diH2O (total volume 20 μl). The mixture 
was incubated at 55°C overnight.  The pHIP-HUT-TR digest was then treated with 1 μl calf 
alkaline phosphatase (1U/μl, Promega) for 30 min at 42°C and the 4.5 kb fragments lacking a 
siRNA insert were purified by cutting out the gel extraction from a 1% agarose gel run in TAE 
and dissolving the gel slice in 3x volume buffer QG (Qiagen) and isolating the DNA on a DNA 
spin columns (Qiagen Cat. No. 28004).  0.1 mM of pHIP-HUT-TR fragment and 10 mM 
representing a 100 fold excess amount of siRNA were ligated in 1 μl T4 DNA ligase 400 U/μl 
(New England BioLabs Inc.), 4 μl 5x T4 DNA ligase buffer and 8.5 μl diH2O (total volume 20 μl) 
and incubated overnight at room temperature.   
10 ml of the pHIP-HUT/siRNA ligation reaction was added to 0.1 ml competent DH5-alpha cells 
and incubated on ice for 30 min.  The plasmids were transfected into the competent cells as 
described above.   
The sequence of pHIP-HUT-TRGFP siR# was confirmed by Sanger di-deoxy sequencing at the 
Oklahoma State University Recombinant DNA/Protein Resource Facility.   
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104 MDA-MB-231 cells were centrifuged at 200 x g for 5 min and resuspended in 100 μl 1x PBS 
(8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4 and 0.24 g KH2PO4 in 1 L at pH 7.4) and incubated on ice 
for 5 min.  The cells were then electroporated with 1 μg pHIP-HUT-TRGFP siR1 or pHIP-HUT-
TRGFP siR3 using a Bio-RAD Gene Pulsar set at 960 μFD, 180 V and 200 OHMS.  The cells were 
then incubated on ice for 5 min then 1 ml growth medium was added and eight 100 μl aliquots 
were placed in a 96 well plate and incubated for 1 hour at 37°C and 5% CO2.  After the recovery 
period Zeocin (Invitrogen Cat. No. R250-01) was added to a final concentration of 500 μg/ml to 
each well and the cells were incubated for 24 hours at 37°C and 5% CO2.   
To induce expression of siRNAs, 1 μg/ml of Doxycyclin (Enzo) was added to 4 of the 8 wells and 
the cells were incubated for 24 hours at 37°C and 5% CO2.  GFP fluorescence was detected using 
the BioTek Synergy H1 Hybrid Reader using an excitation wavelength of 475 and read 
wavelength of 505.  (Figure 2.4) 
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Pulse induction of MEL cells 
Mouse Erythroleukemia (MEL) cells were separated into seven samples, and each sample was 
induced to differentiate into erythrocytes by adding 2% DMSO v/v to growth media at 30-40% 
confluence (Edwards, Harris et al. 1983).  At time points 0.5, 2, 4, 8, 18 and 42 hours the MEL 
cells from separate flasks  were removed and centrifuged at 200 x g, washed with fresh growth 
media and resuspended in 10 ml fresh growth media without DMSO.  The pulse-induced MEL 
cells were then allowed to grow for the duration of the differentiation time (total time 8 days) 
(Figure 2.1).   
As controls, MEL cells were also treated with DMSO for identical times, but the cell RNAs were 
immediately harvested without allowing the cells to grow until terminal differentiation.  These 
RNAs provide a temporal control of induced gene expression during cell culture following 
DMSO treatment.   
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RNA isolation 
RNA was extracted from MEL cells essentially as described by (Hoyt and Doktycz 2004). 
Briefly, MEL cells were centrifuged at 200 x g for 5 min and growth media was decanted.  Any 
remaining media was carefully pipetted off.  The cells were then resuspended in 800 μl buffer 
RLT (Qiagen) with freshly-added β-mercaptoethanol (BME) (15 μl BME for 10 ml RLT).  Cells 
were transferred to a bead milling tube (Bio Plas, Inc., # 4202 and # 4215R) containing seven, 3 
mm borosilicate glass beads (Aldrich # Z14392-8, Milwaukee, WI) and placed on ice.  Cell 
disruption and DNA homogenization was achieved by 6 cycles of 2.5 min shaking and 3 min on 
ice using a 96 well Mini Beadbeater (BioSpec Products Inc.).  A 450 μl aliquot of disrupted cells 
were loaded onto RNeasy spin columns (Quiagen Cat. No. 74106).  The disruption mixture was 
washed and the RNA bound to the columns by centrifugation. Before elution the column was 
treated with 80 μl of DNAse I solution (10 μl DNAse I and 70 μl RDD) and incubated for 30 min 
at room temperature.  Quality of RNA was verified with a non-denaturing 1% agarose gel and 
quantified using an ND-1000 spectrophotometer (Nano Drop). 
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Microarray 
The RNA was prepared for labeling using the Target Amp 1 Round Aminoallyl aRNA 
amplification kit 101 (Epicenter Cat. No TAA1R4924).  The aRNA was cleaned up using RNeasy 
spin columns and cDNA was digested on column using 80 μl of RNase-free DNAse I solution (10 
μl DNAse I and 70 μl RDD).  The aRNA eluted from the column was then quantified using the 
ND-1000 spectrophotometer and quality was checked using Agilent RNA 6000 Nano Kit on the 
Agilent 2100 Bioanalyzer. Approximately 15-20 mg of aRNA was concentrated using a Savant 
ISS110 SpeedVac Concentrator (Thermo Scientific) on the low temperature setting to a volume 
of 5 μl.  Three μl of labeling buffer (25 mg NaHCO3 in 1 ml nuclease free H2O) were added to the 
aRNA sample.  One tube each from a Decapack of NHS Alexa Fluor dyes 488, 555 and 647 
(Invitrogen) was dissolved in 2 μl of anhydrous DMSO and vortexed for 10 sec to mix.  Eight μl 
of aRNA in labeling buffer were added to the dye, vortexed briefly to mix and incubated at room 
temperature in the dark for 1 to 1.5 hours.   
Unincorporated label and buffers were removed from the labeled aRNA using RNeasy spin 
columns (Qiagen Cat. No. 74106) and the aRNA and dye concentrations were determined using 
the ND-1000 Spectrophotometer.  For each labeled aRNA, an aliquot representing 60 pMol of 
dye was dried in the dark using Savant ISS110 SpeedVac Concentrator (Thermo Scientific) on 
the low temperature setting.  For microarray hybridizations, control aRNA labeled with Alexa 
Fluor 488 was mixed with two aRNA timepoints labeled with Alexa Fluor 555 and 647 in 
equimolar amounts of fluorescent dyes, and resuspended in 42.5 μl nuclease free H2O and 42.5 μl 
2x hybridization buffer (40-70% deionized formamide, 10x SSC and 0.2% SDS). Experiments  
were done in triplicate and dyes were swapped between samples of different experiments.  The 
labeled aRNA mixture was denatured at 95°C for 2 min prior to adding the targets to the 
microarray.  The aRNA mixture was pipetted onto a Meebo ReadyArray MM1100 (Microarray 
Inc.) and a cover slip was placed onto the array.  The arrays were hybridized in a Corning 
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hybridization chamber and incubated at 42°C and 100% humidity overnight.  The arrays were 
then incubated in 10 ml of wash solution 1 (2x SSC and 0.1% SDS) at 42°C for 5 min, transferred 
to 10 ml of wash solution 2 (0.1x SSC and 0.1% SDS) for 5 min at room temperature, and then 
washed twice in wash solution 3 (0.1x SSC) at room temperature for 1 min each.  Arrays were 
blown dry with pressurized, filtered air and scanned using Axon GenePix 4400A array scanner 
(MDS analytical technology) and analyzed using GenePix Pro 7.  Normalization of arrays was 
done using GenePix auto processor (GPAP) v3.2 (http://darwin.biochem.okstate.edu/gpap32/) 
using Global Loess Normalization and regression background correction.   
GOterms were identified using DAVID (http://david.abcc.ncifcrf.gov/).   
K-mean clustering by gene was done using Multi Expression Viewer (MeV) v4.9.0 with a 
Pearson Correlation Matrix of 9 clusters and a maximum iteration of 50. 
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Figure 2.1: Workflow for pulsed induction method
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Oligo 
name  
Sequence 
H1 DN 5’-CAGGATCCACTTATAACTCTATCAATGATAGAGTCATTTCACGTTTATGGTGATTTCCC-
3' 
U6 UP 5'-GACGCTAGCCACAAGATATATAACTCTATCAATGATAGAGTCTTTCAAGTTACGG-3' 
H1 RC 
Shift 
5'-CGTGAAATGACTCTATCATTGATAGAGTTATAAGTGGATCCTGAGACCG-3' 
H1 UP 5’-GCGATATCACTAGGGGGAGGC-3’ 
 
U6 DN 5’-CCACGCGTCCCCAGTGGAAAGACGC-3’ 
 
 Table 2.2.1: Oligonucleotides used for construction of pHIP-HUT.  Blue sequence represents the 
TetR binding site and the underlined sequences are the degenerate portion of the primers 
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siRNA name Oligonucleotide pair Sequences 
copGFP siRNA 1  5’-AAAACAACAACGGCGGCTACACCAA-3’ 
           3’-GTTGTTGCCGCCGATGTGGTTAAAA-5’ 
copGFP siRNA 2  5’-AAAATCCCGCGCTCAGTCGTCCAAT-3’ 
           3’-AGGGCGCGAGTCATCAGGTTAAAAA-5’ 
copGFP siRNA 3 5’-AAAAGAGAGCGACGAGAGCGGCCTG-3’ 
            3’-CTCTCGCTGCTCTCGCCGGACAAAA-5’ 
No target 
transfected 
siRNA 
5’-AAAACCAACCTCACCTCAACTTCAT-3’ 
          3’-GGTTGGAGTGGAGTTGAAGTAAAAA-5’ 
Table 2.2: siRNA oligos for insert into pHIP-HUT-TR transcription site with 4A 5’ sticky ends.   
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Figure 2.2: pHIP-HUT-TR and pHippy 
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Figure 2.3: Sewing PCR of H1TetO and H1 RC Shift fragments 
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Figure 2.4: GFP emissions in MDA-MD-231 GFP/RFP stable cell line (Cell BioLab Inc.) 
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CHAPTER III 
 
 
RESULTS AND DISCUSSION  
 
 
Cell proliferation  
To determine the effects of pulsed induction with 2% DMSO on proliferation and cell growth, I 
induced cells for 0, 0.5, 2, 12 and 18 hours and compared them to constitutively induced cells 
(Figure 3.1).  There was no significant difference between proliferation of pulsed induced and 
non-induced (0 hour) cells.  This finding indicates that treating cells with 2% DMSO will not 
adversely affect cell survival or proliferation.  However, the constitutively induced cells begin to 
plateau two days earlier at day 3, whereas pulse-induced and control cells plateau at day 5 and 
at much higher cell density.  The fold change in the constitutively induced cells, > 8 and < 16, 
indicates that MEL cells go through 4 divisions when undergoing terminal differentiation.   
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Microarray  
Microarrays while limited to the probes on the array generate vast amounts of data.  In order to 
reduce the complexity of the data many genes were filtered by certain criteria.  First, genes that 
are differentially expressed (p-value of < 0.05) in both induced and recovered cells were sorted 
into two major categories; persistent differentially expressed genes and genes that showed 
opposed or compensatory expression (Table 3.1).  Genes that showed persistent expression or 
opposed expression are considered candidate genes for further investigation.  Genes that 
showed persistent expression changes are important for determination and/or differentiation.  
Genes that showed a compensatory change are ether 1) required for self-renewal or 2) only 
transiently required for determination or differentiation.   
The increase in genes that are persistently expressed at the 18 hour time point indicates that 
some determination event had occurred during the 18 hours of induction.  This was further 
supported by examining the effects on cell cycle genes (Figure 3.2).  Seventeen genes known to 
be involved with cell cycle control showed persistent expression changes with a p-value of < 
0.05 after recovery in the 18 hour time points, whereas none show a persistent change in the 2 
hour time point and only 4 (Ccna1, Cdk1, Cdc25a and Cdc25c) showed changes in the 0.5 hour 
time point.  Genes that showed persistent expression at the 18 hour time point have a greater 
change when recovered in 89.5% of the genes (Table 3.2), i.e. genes that are up-regulated 
become more up-regulated and down-regulated genes become more down-regulated after the 
inducing agent is removed.  Contrary to the 18 hour time point, the 0.5 and 2 hour time points 
only have 16.7% and 26.3% of genes that have greater changes respectively.  While at the
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earlier time points, the genes showed persistent expression, most seem to be reverting towards 
the pluripotent state.   
After categorizing the genes into the two categories, persistently expressed and opposing 
expression, four genes showed persistent expression and two genes showed opposing 
expression at all time points (Figure 3.12).  The genes common in the persistent category are 
Slc17a6, Ifit1, Serpine2 and Zmym4, the genes common to the opposing category are Flt4 and 
Musk.  Slc17a6 (solute carrier family 17 member 6) is a vascular glutamate transporter.  Slc17a6 
facilitates the uptake of glutamate in synaptic vesicles (Bai, Xu et al. 2001).  Ifit1 (Interferon 
induced protein 1) with tetratricopeptide receptor 1 plays a role in inhibiting viral translation by 
binding to single stranded RNA with a 5’ triphosphate group (PPP-RNA) (Fensterl, White et al. 
2008).  Serpine2 (serpin peptidase inhibitor clade E nexin plasminogen inhibitor type 1 member 
2) inhibits enzymes such as thrombin, trypsin, urokinase and promotes neurite extension (Heit, 
Jackson et al. 2013).  Zmym4 (zing finger MYM type 4) plays a role in cell morphology and 
cytoskeletal organization (Smedley, Hamoudi et al. 1999).  Flt4 (Fms related tyrosine kinase 4) is 
a cell surface receptor for vascular endothelial growth factors VEGFC and VEGFD (Galland, 
Karamysheva et al. 1993).  Flt4 plays a role in lymphangiogenesis, development of the vascular 
network and cardiovascular system.  Flt4 promotes proliferation, cell survival and migration of 
endothelial cells.  MUSK (muscle skeletal receptor tyrosine kinase) is involved in MAPK signaling.  
MUSK is involved in the maintenance of neuromuscular junction regulates the actin 
cytoskeleton and clustering of the acetylcholine receptor (DeChiara, Bowen et al. 1996). 
To identify genes involved in self-renewal I looked at genes that were down-regulated when 
cells were induced and up-regulated when they recovered.  Several Rho protein expressions fit 
this pattern (Figure 3.3) which makes these excellent candidates for self-renewal.  Rhoa and 
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Rhot1 are small GTPases that act as secondary signaling molecules to propagate signals within a 
cell.  RhoBTB1 and Arhgef5 are Rho guanine nucleotide exchange factors that exchange GDP for 
GTP in Rho proteins, promoting their activity.  Rtkn is a scaffolding protein that interacts with 
the active GTP bound form of Rho proteins.  All these proteins have the same expression 
patterns, when induced: the abundance of transcripts dropped and, when the cells were 
allowed to recover, their expression increased to help the cell recover to the pluripotent state.  
This is further supported by the expression of Arhgap24 which is a Rho GTPase activating 
protein.  This causes the catalysis of GTP to GDP inactivating the Rho protein.  Arhgap24 showed 
the inverse expression of all the other Rho proteins identified in this study.  When induced 
Arhgap24 turns off the Rho protein signaling and when the cells are allowed to recover the 
expression of Arhgap24 dropped off releasing the repression of the Rho proteins.  Furthermore 
even after a determination event the Rho proteins still play a role in self-renewal of the cells 
that are in an intermediate state.  
Other proteins that showed expression patterns suggesting they are involved in self-renewal are 
ubiquitin and SUMO.  Ubiquitin and SUMO, while it is difficult to determine just how and what 
they are interacting with, I hypothesize that genes following this pattern of expression (Figure 
3.4), regulate differentiation and promote self-renewal.  Furthermore SUMO and ubiquitin may 
play a role in erasing memory of MEL cells.  The Ubiquitin C gene Ubc was down-regulated when 
induced and up-regulated during recovery at the 2 and 18 hour time points.  Ubc may regulate 
transcription factors through protein degradation or modify proteins, changing their kinase 
activities.  The SUMO genes sumo3 and sae1 showed the same pattern of gene expression at the 
18 hour time point.  Sumo3 is a small ubiquitin-like molecule that can post-translationally 
modify lysines of other peptides possibly altering the function of the proteins or targeting the 
proteins for degradation.  Sae1 is responsible for catalyzing isopeptide bond formation with 
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SUMO.  Senp3, in contrast to Sae1, hydrolyses the isopeptide bond of a SUMOlated protein 
causing the release of SUMO.  Senp3 showed up-regulation when cells were induced and 
becomes down-regulated when they were allowed to recover indicating that de-SUMOylation of 
some proteins may be important for progression of commitment or differentiation.   
Mechanistic target of rapamycin complex 2 (mTORC2) plays a role in protein synthesis and the 
PIP3/Akt signaling pathway.  The major components of the complex are mtor, Rictor and mist 
(Figure 3.5).  Mist8 is the only major component that showed significant changes in both 
induced and recovered cells and follows the pattern that suggests the gene is involved in self-
renewal.  Rictor showed the same pattern and was significantly down-regulated when induced.  
However, its change in the recovered cells, while elevated, is not significant, indicating that 
Mist8 may be a major regulator for the complex during erythropoiesis.  Mtor expression was 
lower in induced and recovered cells but the changes were not significant with a p-value > 0.05.  
Overall this suggests that mTORC2 may play a role in self-renewal.   
Transporters may play a role in bringing signaling molecules into the cell and regulating the pH 
of the cytoplasm as the cell changes from basophilic to acidophilic (Figure 3.6).   Slc10a4 is an 
orphan of the Slc10a family that transports bile acids.  While the substrate of Slc10a4 is not 
known, its expression indicates that it may play a role in self-renewal.  Slc10a4 is most similar to 
Slc10a1 and is likely to transport an organic acid, which may also regulate the pH in the 
basophilic cytoplasm of proerythroblasts and basophil erythroblasts.  As the cells differentiate 
and the cytoplasm becomes more acidic, Slc17a6 can sequester glutamate in vesicles; Slc17a6 is 
also a good candidate gene for commitment because it is persistently expressed at all time 
points.  Not only do the cells sequester acidic amino acids but Slc7a2 transports arginine into the 
cell to help regulate cytoplasmic pH.  Arginine is also the substrate for nitric oxide synthases 
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(NOS) which will produce NO which may act as a paracrine signaling molecule and also 
competitively bind heme to prevent developing cells from pulling an over-abundant amount of 
O2 out of the blood before they begin circulation.   
FLT4 may play a role in signaling changes to the cell cycle during differentiation.  Flt4 was up-
regulated during all time points when cells were induced and down-regulated when they 
recovered (Figure 3.7).  Flt4 responds to VEGFC and VEGFD, propagating the signal to RASA1 
which in turn can phosphorylate CIP1 and KIP1, causing the switch in the cell cycle.  Rasa1 was 
up-regulated when cells were induced at all time points, but when they recovered, changes in 
Rasa1 were not significant.  Because of Flt4’s compensatory changes, it is possible that Flt4 is 
only transiently activated during differentiation thus its expression is not required to continue 
when the signal has been passed to downstream targets.  
The vasopressin receptor Avpr1B, like Flt4, may also be a transiently activated signal for 
commitment.  Avpr1B is a G-protein coupled receptor and Grk5 is released when Avpr1B binds 
vasopressin.  Similar to Flt4, Avpr1B only showed a transient activation (Figure 3.8) where it is 
up-regulated when cells were induced and down-regulated when they recovered.  Conversely, 
Grk5 was persistently expressed and showed a marked increase in recovered cells compared to 
induced cells.  Because both increased at the 2 hour and not at the 0.5 hour time point, it is 
likely that Avpr1B is not one of the first responders to the induction but may be involved in 
transmitting the signal for commitment to downstream transcription factors such as NF-kB1 
Mitogen activated protein (MAP) kinases Mapk3, Map3k8 and Map3k14 all showed up-
regulation when cells were induced at 2 hours but reverted to normal levels when they 
recovered. However, at 18 hours, Map3k8 and Map3k14 showed opposing expression (Figure 
3.9).  This indicates that Map3k8 and Map3k14 may only need to be transiently activated during 
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differentiation, activating other proteins such as transcription factors.  Mapk3 induction 
dropped off from 2 to 18 hours of induction but, when cells were allowed to recover after 18 
hours, Mapk3 showed a strong, persistent up-regulated change.  This may allow for persistent 
activation of many MAP kinase targets to be active causing a permanent change from the 
original pluripotent state of the control cells.   
Many transcription factors or components of a transcription factor complex were differentially 
expressed, several of which are targets of MAP kinases such as NF-kB1, Myc, Pou2af1 and Mef2c 
(Figure 3.10a).  Not only is nuclear factor kappa B 1 (NF-kB1) activated by MAP kinases it may 
also be activated by vasopressin stimulation.  NF-kB1 is a transcription factor that activates a 
variety of biological processes. While NF-kB1 was induced at 2 hours, NF-kB1 didn’t show 
persistent expression until 18 hours.  With its early induction and persistent expression after 18 
hours, NF-kB1 may transcribe genes required for commitment and maintain the subsequent 
intermediate state.  It is also suspected that NF-kB1 plays a role in the formation of cardiac 
muscle, so it may be a nonspecific regulator of vascular differentiation.  Myc is a transcription 
factor that targets cell cycle progression genes and has been implicated in various 
hematopoietic processes including erythropoiesis.  Myc was up-regulated and showed 
persistent expression only at the 0.5 hour time point but was up-regulated during all time points 
in induced cells.  Along with Cip1 and Kip1, Myc may regulate the changes in the cell cycle when 
differentiation is induced.  Pou2af1 is a transcriptional coactivator that is known to associate 
with Oct1 or Oct2 by recognizing the POU domain.  Pou2af1 expression was up-regulated at all 
time points and was persistently expressed at 18 hours.  Based on the expression of Oct1 and 
Oct2 (Pou2f1 and Pou2f2, respectively) (Figure 3.10b), Pou2af1 interacts with Oct2 and not Oct1 
to promote commitment.  Mef2c is a transcriptional enhancer that has been reported to play a 
role in myogenesis and maintaining the differentiated state of muscle cells.  Mef2c was 
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persistently expressed at 18 hours and was greatly up-regulated in recovered cells.  Given its 
role in muscles and its expression in erythropoiesis, Mef2c may promote the transcription of 
commitment genes and help maintain the intermediate state.   
During erythropoiesis changes in the cytoskeleton are required to give the erythrocytes their 
donut shape; however, changes in the cytoskeleton start occurring immediately after induction 
and some changes persist even before commitment.  Cytoskeleton regulatory proteins Zmym4 
and Stmn2 may play a role in the reorganization of the cytoskeleton during differentiation of 
erythrocytes (Figure 3.11).  Stmn2 was persistently up-regulated at the 18 hour time point and is 
known to be involved in neuronal growth and osteogenesis. Zmym4 also regulates interactions 
between the cytoskeleton and the membrane and was persistently down-regulated at all time 
points.  The persistent down regulation of Zmym4 indicates that cytoskeletal organization may 
be important for self-renewal and may be one of the first changes to occur.  Stem2, in the 
absence of Zmym4, may regulate the structural changes of the cytoskeleton in a developing 
erythrocyte post commitment.   
To compare our data to the literature I created a list of 35 genes known to be involved with 
erythropoiesis (Table 3.3) (Müllner, Dolznig et al. 1996; Trumpp, Refaeli et al. 2001; Dolznig, 
Grebien et al. 2006; Ghaffari, Kitidis et al. 2006; Heuser, Yap et al. 2009; Harandi, Hedge et al. 
2010; Rowlinson and Gering 2010; Hattangadi, Wong et al. 2011; He, Kim et al. 2011; Zhou, 
Wang et al. 2011; Cai, Langer et al. 2012; Sankaran, Ludwig et al. 2012; Trowbridge and Orkin 
2012; Zhang, Prak et al. 2013).  I found 63% (22/35) of the genes represented on the list 
matched our list of candidate genes.  Perhaps the genes that were not found in our list of 
candidate genes were not found because I was only looking at early time points of induction 
from cells in the proerythroblast stage. 
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Gene Ontology 
In order to elucidate what cellular processes were accruing, gene ontology terms were identified 
with a shared GO term search with a p-value cut off for over expressed GO terms of < 0.05  
(Table 3.4).  At the 0.5 hour time point heparan sulfate sulfotransferase activity was a GO term 
identified. Heparin sulfate plays a role in maintaining the membrane.  This is not surprising 
considering the cells were treated with DMSO which disrupts membranes.  Apolipoprotein 
binding was also identified, indicating that a lot of interactions are occurring at the membrane.  
This is further supported by calcium ion binding, calcium-dependent phospholipid binding 
activity and inositol 1, 4, 5 trisphosphate binding.  Additional GO categories identified that may 
play a role in signal transduction are, guanyl nucleotide exchange factor activity, carboxylic acid 
binding and transport and nitric oxide synthase regulator activity.  Carboxylic acid binding and 
transport activity also indicate transporters playing a role in maintaining pH of the cytoplasm.  
Arginine is brought into the cell during differentiation, which may regulate the pH as cells 
become more acidophilic; however, arginine is also the substrate for nitric oxide synthase (NOS) 
indicating that nitric oxide (NO) may play a role in a developing erythrocyte.  NO can act as a 
paracrine signaling molecule causing the formation of cyclic GMP, or it can competitively bind 
heme preventing oxygen from the blood being pulled away by non-circulating developing 
erythrocytes.  Also, as expected in developing erythrocytes, heme binding was represented in 
the GO terms.  
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Pathway analysis 
For the pathway analysis, the expression data of opposing and persistently expressed genes 
were analyzed separately using reactome.org’s (http://www.reactome.org/) analysis tools.  The 
opposing expressed genes showed the same pattern in all time points for signaling of Rho 
GTPases.  The Rho GTPase signaling pathway was down-regulated when cells were induced and 
when cells were allowed to recover the Rho GTPase pathway was up-regulated.  This made the 
Rho signaling a good starting point for building a model for self-renewal in MEL cells.  
Interestingly the SUMOylation pathway had the greatest mean difference of all the pathways 
identified by reactome.org.  The mean difference of expression in a pathway is the change in all 
genes associated in the pathway when comparing induced and recovered cells.  This indicates 
that SUMO could play an important role in self-renewal by posttranslationally regulating 
proteins.  Some other pathways that were well represented and matched some of the GO terms 
are PIP3 and Akt signaling.  The largest pathway for genes that were persistently expressed and 
up-regulated was the mitogen activating protein kinase (MAPK) cascade.  Other pathways that 
had high mean changes are ‘binding and uptake of ligands by scavenging’ and ‘extracellular 
matrix organization’ which were greater than four fold up-regulated while DNA replication was 
down-regulated.  Similar to gene expression at the 18 hour time point, about 90% all pathways 
that showed a persistent change had a higher mean change in the recovered cells (Table 3.5).   
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Protein-protein interactions 
To look at protein-protein interactions I used the web tool STRING (http://string-db.org/).  Using 
opposing expressed genes that showed down-regulation when cells were induced and up-
regulation when they recovered I was able to link Rho GTPases, GTPase activator proteins 
(GAPs) and GTPase enhancer proteins (GEFs) to Akt3 and mTORC2.  I then added erythropoiesis 
markers to the list of candidate genes, to identify any interactions between candidate genes and 
known markers (Figure 3.13).  With these interactions I began building a model for self-renewal 
around the Rho proteins.  To look at commitment I used persistently expressed genes that were 
up-regulated and filled in some of the gaps with genes that were up-regulated when induced in 
all 3 time points even if they were not persistently expressed.  Many of the interactions 
centered around MAPK proteins.  Some of the candidate genes that were linked to the MAPK 
cascade are the vasopressin G-protein coupled receptor, Flt4 and several transcription factors.  I 
then added the erythropoiesis markers to identify how our candidates may interact with known 
genes (Figure 3.14).   
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Model 
The self-renewal model (Figure 3.15) was made using primarily genes that were down-regulated 
when cells were induced and up-regulated when they recovered.  This is because the genes with 
this expression pattern are compensating for the changes that occur during the short induction 
period, indicating the genes are responsible for maintaining the self-renewal capabilities of the 
pluripotent cell.  By using the information provided by gene ontology, pathway analysis and 
STRING protein-protein interactions I developed a model in which PIP3 signals mTORC2, which 
regulates Akt3 and several Rho GTPases which in turn regulate cell cycle control genes Cip1 and 
Kip1 and the transcription factor GATA1.  Rho GTPases along with CDC42 regulate cell survival.  
mTORC2 can also regulate protein synthesis by regulating eukaryotic initiation factors, several of 
which are identified as candidates for self-renewal by their expression patterns.  Furthermore, 
protein synthesis decreases as the cells differentiate into erythrocytes (Wang and Proud 2006), 
which supports the idea that mTORC2 needs to be down-regulated as cells differentiate.  
Another feature of my model is the transporter Slc10A4, which may bring in an early signal for 
differentiation or commitment.  Slc10A4 shares a similar expression pattern as other members 
of the model. Other members of the Slc10A family transport bile acids into the cell; however, 
Slc10A4 is an orphan in the Slc10A family because it does not transport bile acids.  Given its 
similarity to Slc10A1, it may transport an organic acid into the cell which could act as signaling 
molecule and help regulate the pH as the cell is basophilic during the early stages of 
differentiation.   
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The model for commitment (Figure 3.16) was made with persistently expressed genes and genes 
up-regulated during induction to fill in putative gaps in the protein-protein interactions.  Genes 
that show a persistent change may be associated with commitment because, if the changes are 
permanent, this indicates the cells did not revert to their original pluripotent phenotype when 
cells were allowed to recover.  Genes that revert to basal levels or become down-regulated may 
only be transiently required for commitment or differentiation.  In the commitment model the 
amino acid transporter Slc7a2 brings in L-arginine into the cell and Slc17a6 sequesters glutamate 
in vesicles to help regulate cytoplasmic pH as the cells become more acidophilic.  The Vascular 
Endothelial Growth Factor Receptor 3 (VEGFR3 also called Flt4) can signal the switch to the 
differentiation cell cycle by activating the CDK inhibitors Cip1 and Kip1.  During early time points 
the vasopressin receptor Avpr1B, along with a MAPK cascade, signals various transcription 
factors Mef2c, Pou2af1, NF-kB and Rad18 and cytoskeleton/membrane interaction regulator 
protein Stmn2.  Stmn2 and Zmym4 may control the change in shape from a globular cell to the 
donut shaped erythrocyte.   
53 
 
pHIP-HUT-TR construction and validation.   
pHIP-HUT-TR (Figure 3.1 Materials and Methods) was constructed as described in Materials and 
Methods, and the sequence of the modified promoters was confirmed using Sanger di-deoxy 
DNA sequencing (Figure 3.17).   
Validation of pHIP-HUT-TR was done by knockdown of copGFP using siRNA (Table 3.2 Materials 
and Methods).  First, the limit of detection was determined by taking GFP fluorescence readings 
of MDA-MB-231 GFP/RFP stably transformed cells (Figure 3.18).  For detection above 
background, it was determined that 6.27x10
4
 cells would be needed.  Although some 
experiments clearly showed a knockdown effect (2 of 4 biological replicates) of the siRNA siR1 
and siR3 (Figure 3.19), the combined experiments showed inconsistent knockdown of the GFP 
expression. Overall, 2 biological replicates showed about a 50% decrease in fluorescence 
whereas 2 showed no significant decrease.  The variations in the biological replicates could be 
due to inconsistent transformation of cells.   
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Conclusions 
I have developed a novel method that I am calling pulsed induction to identify genes involved in 
determination events and self-renewal.  Using this method I was able to identify many genes 
that have been identified as being involved with erythropoiesis as well as many genes that may 
play a novel role in the development of erythrocytes.  Using various bioinformatics tools, I have 
developed a model for self-renewal and commitment.  The model illustrates how some of the 
novel genes may play a role in regulating known markers of erythropoiesis.  Future work would 
involve validating models designed using the pulsed induction method.   
I also constructed an inducible bi-directional siRNA expressing vector pHIP-HUT-TR which uses a 
tetR system to control expression of the inserted siRNA.  However, experiments testing its gene 
silencing ability remain inconclusive as only half of the biological replicates seemed to show a 
50% knock down and two showed no significant changes, making the average around 75% knock 
down with high variation.  Further testing of pHIP-HUT-TR needs to be done with various siRNA 
and cell lines to further validate the vector.    
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 Figure 3.1: Cell proliferation of pulsed induced cells.  Cells constitutively induced (light blue line) 
plateau around day3 whereas 0, 12 and 18 plateau around day 5 and 2 hours never plateaus but 
its growth does slow.   
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Number of genes that show differential expression in persistent and opposed gene expression 
categories by time point 
Time point Total differentially 
expressed genes 
Genes with persistent 
expression 
Genes with opposed 
expression 
0.5 hour Induced 3513 468 479 
0.5 hour recovered 7100   
2 hour Induced 4807 133 63 
2 hour recovered 1088   
18 hour Induced 5787 1320 1549 
18 hour recovered 15354   
Table 3.1: Number of genes differentially expressed at the time points as well as the number of 
genes that are persistently expressed and have opposing expression all with a p-value of < 0.05. 
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Figure 3.2: Gene expression for 17 cell cycle genes that show persistent changes in the 18 hour 
recovery cells.  
  
-4
-3
-2
-1
0
1
2
3
Lo
g
2
 r
a
ti
o
s
Cell Cycle Changes in Recovered MEL Cells
0.5 hour recovered
2 hour recovered
18 hour recovered
58 
 
Time point % of persistent genes with a 
greater change in recovered cells 
0.5 hour 16.7% 
2 hour  26.3% 
18 hour 89.5% 
Table 3.2: Percentage of persistently expressed genes that show a greater change in recovered 
cells when compared to induced cells, indicating that an epigenetic event has accured between 
2 hour and 18 hour.   
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A         B 
 
C 
 
Figure 3.3: Rho proteins and Rho associated proteins that show opposing expression at different 
time points.  A B and C show Rho proteins at the 0.5 hour, 2 hour and 18 hour time points 
respectively.   
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A             B 
 
Figure 3.4: A. gene expression for Ubc at 2 hour and 18 hour time points.  B. SUMO related 
genes sumo3, sae1 and senp3 gene expression at the 18 hour time point.   
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Figure 3.5: mTOR complex 2 major components’ gene expression.  Mtor expression, while down 
is not significantly differentially expressed in ether Induced or recovered cells, nor is Rictor in 
recovered cells.   
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Figure 3.6: Gene expression of solute carrier transport proteins SLC7a2, Slc17a6 and Slc10a4 
after 2 hour of induction and recovery.   
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Figure 3.7: Gene expression of Flt4 and Rasa1 at the 18 hour time point.   
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Figure 3.8: Gene expression of the vasopressin receptor Avpr1b and its associated G-protein 
Grk5 at the 2 hour time point.   
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Figure 3.9: Gene expression of mitogen activated protein kinases that have known or predicted 
interactions with several candidate genes.  
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Figure 3.10: A) Gene expression of transcription factors Myc and NF-kB1 at the 2 hour time point 
and transcription activators/enhancers Pou2af1 and Mef2c at the 18 hour time point. B)Gene 
expression of Oct1 and Oct2 (Pou2f1 and Pou2f2 respectively).   
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Figure 3.11: Gene expression of cytoskeleton regulator proteins at the 18 hour time point.   
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Figure 3.12: The top Venn diagram shows the all persistently expressed genes whereas the 
bottom Venn diagram show all genes with opposing expression in all time points.   
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 Gene symbol  Candidate genes identified by pulse 
induction 
1 GATA1 Yes 
2 Runx1 Yes 
3 Dnmt3a Yes 
4 E2f2 Yes 
5 E2f8 Yes 
6 Notch2 Yes 
7 GATA2 No 
8 GATA3 No 
9 Cdkn1a (p21) No 
10 Cdkn1b (p27) Yes 
11 Cdc42 No 
12 Jagged 2 No 
13 Sfpi1 No 
14 BMP4 Yes 
15 Akt1 No* 
16 Myc Yes 
17 Klf1 No* 
18 Epor Yes 
19 Smad5 Yes 
20 Lmo2 Yes 
21 Suz12 Yes 
22 Ezh2 Yes 
23 P300 Yes 
24 Lmo2 Yes 
25 Hbb Yes 
26 Sox17 No* 
27 Bmi1 Yes 
28 ZFP36 Yes 
29 Meis1 No 
30 MLL5 Yes 
31 STAT1 Yes 
32 Jak1 Yes 
33 STAT5 No* 
34 FOG1 No 
35 Lsd1 No 
Table 3.3: Several genes involved in erythropoiesis and whether or not our pulsed induction 
method has identified them as candidate genes.  * indicate that a member of the same family 
was identified e.g. akt3 instead of akt1.   
  
70 
 
 
GO term 
Heparan sulfate sulfotransferase activity 
Apolipoprotein binding 
Calcium ion binding 
Calcium dependent phospholipid binding 
Guanyl nucleotide exchange factor activity 
Carboxylic acid binding 
Carboxylic acid transmembrane transport activity 
Heme binding 
Nitric oxide synthase regulator activity 
Inositol 1, 4, 5 trisphosphate binding 
Table 3.4: Gene Ontology categories of candidate genes  
71 
 
 
Table 3.5: Pathway analysis of the 18 hour time point, with induced expression on the left and 
recovered expression on the right.   
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Figure 3.13: STRING protein-protein interactions for self-renewal.  Candidate genes are indicated 
by black boxes and erythropoiesis markers are indicated by red boxes.  The lines between 
proteins indicate how the interaction has been determined from the STRING database.   
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Figure 3.14: STRING protein-protein interactions for commitment.  Candidate genes are 
indicated by black boxes and erythropoiesis markers are indicated by red boxes.  The lines 
between proteins indicate how the interaction has been determined from the STRING database.   
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Figure 3.15: Model for self-renewal. Genes in red are > 1.5 fold up-regulated and genes that are 
green are > 1.5 fold down regulated while genes that are yellow are neither.  A. shows gene 
expression in the pathway for recovered cells.  The model illustrates how mTORC2 and Akt3 
regulate cell cycle control genes Cip1 and Kip1, GATA1 as well as Rho G-proteins, which can 
regulate cell cycle control genes and cell survival with CDC42.  B. shows the same model during 
induction. 
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Figure 3.16: Model for commitment.  Genes in red are > 1.5 fold up-regulated and genes that are 
green are > 1.5 fold down regulated while genes that are yellow are neither.  This model illustrates 
how the MAPK cascade regulates transcription factors identified with the pulsed induction method 
as well as how two receptors, Avpr1B and the Flt4 receptor, signal other molecules to promote 
commitment and/or differentiation.  Amino acid transporters may also play a role in maintaining 
cytoplasmic pH as the cells become more acidophilic.    
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Figure 3.17: TetR binding sequence in U6 (Top) and H1 (bottom) in pHIP-HUT-TR are highlighted in 
the red box.   
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Figure 3.18: Detection limit of fluorescence of copGFP in MDA MB-231 GFP/RFP cells (Cell BioLabs 
Inc.) using 1.255x10
6
 cells/ml in the undiluted sample (250/0) 
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Figure 3.19: Knockdown of GFP in MDA 231 GFP/RFP cells using Mock transfected, No target siRNA, 
siRNA 1 and siRNA3 when induced with Doxycycline.  All fluorescence is relative to the non-induced 
control that was transformed or mock treated.  
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APPENDICES 
 
 
 
 
pHIP-HUT-TR sequence 
 
   1 CAATTCGCCA GGAACCGTAA AAAGGCCGCG TTGCTGGCGT TTTTCCATAG 
   51 GCTCCGCCCC CCTGACGAGC ATCACAAAAA TCGACGCTCA AGTCAGAGGT 
  101 GGCGAAACCC GACAGGACTA TAAAGATACC AGGCGTTTCC CCCTGGAAGC 
  151 TCCCTCGTGC GCTCTCCTGT TCCGACCCTG CCGCTTACCG GATACCTGTC 
  201 CGCCTTTCTC CCTTCGGGAA GCGTGGCGCT TTCTCATAGC TCACGCTGTA 
  251 GGTATCTCAG TTCGGTGTAG GTCGTTCGCT CCAAGCTGGG CTGTGTGCAC 
  301 GAACCCCCCG TTCAGCCCGA CCGCTGCGCC TTATCCGGTA ACTATCGTCT 
  351 TGAGTCCAAC CCGGTAAGAC ACGACTTATC GCCACTGGCA GCAGCCACTG 
  401 GTAACAGGAT TAGCAGAGCG AGGTATGTAG GCGGTGCTAC AGAGTTCTTG 
  451 AAGTGGTGGC CTAACTACGG CTACACTAGA AGGACAGTAT TTGGTATCTG
98 
 
 
  501 CGCTCTGCTG AAGCCAGTTA CCTTCGGAAA AAGAGTTGGT AGCTCTTGAT 
  551 CCGGCAAACA AACCACCGCT GGTAGCGGTG GTTTTTTTGT TTGCAAGCAG 
  601 CAGATTACGC GCAGAAAAAA AGGATCTCAA GAAGATCCTT TGATCTTTTC 
  651 TACGGGGTCT GACGCTCAGT GGGCGGCCGC ATTTGCATGT CGCTATGTGT 
  701 TCTGGGAAAT CACCATAAAC GTGAAATGAC TCTATCATTG ATAGAGTTAT 
  751 AAGTGGATCC TGAGACCGTC TCAAAAAGCA AGCTGACCCT GAAGTTCATT 
  801 TTTTGAGACG CTAGCCACAA GATATATAAC TCTATCAATG ATAGAGTCTT 
  851 TCAAGTTACG GTAAGCATAT GATAGTCCAT TTTAAAACAT AATTTTAAAA 
  901 CTGCAAACTA CCCAAGAAAT TATTACTTTC TACGTCACGT ATTTTGTACT 
  951 AATATCTTTG TGTTTACAGT CAAATTAATT CTAATTATCT CTCTAACAGC 
1001 CTTGTATCGT ATATGCAAAT ATGAAGGAAT CATGGGAAAT AGGCCCTCTT 
1051 CCTGCCCGAC CTTGGCGCGC GCTCGGCGCG CGGTCACGCT CCGTCACGTG 
1101 GTGCGTTTTG CCTGCGCGTC TTTCCACTGG GGACGCGTTG ACATTGATTA 
1151 TTGACTAGTT ATTAATAGTA ATCAATTACG GGGTCATTAG TTCATAGCCC 
1201 ATATATGGAG TTCCGCGTTA CATAACTTAC GGTAAATGGC CCGCCTGGCT 
1251 GACCGCCCAA CGACCCCCGC CCATTGACGT CAATAATGAC GTATGTTCCC 
1301 ATAGTAACGC CAATAGGGAC TTTCCATTGA CGTCAATGGG TGGAGTATTT 
99 
 
1351 ACGGTAAACT GCCCACTTGG CAGTACATCA AGTGTATCAT ATGCCAAGTA 
1401 CGCCCCCTAT TGACGTCAAT GACGGTAAAT GGCCCGCCTG GCATTATGCC 
1451 CAGTACATGA CCTTATGGGA CTTTCCTACT TGGCAGTACA TCTACGTATT 
1501 AGTCATCGCT ATTACCATGG TGATGCGGTT TTGGCAGTAC ATCAATGGGC 
1551 GTGGATAGCG GTTTGACTCA CGGGGATTTC CAAGTCTCCA CCCCATTGAC 
1601 GTCAATGGGA GTTTGTTTTG GCACCAAAAT CAACGGGACT TTCCAAAATG 
1651 TCGTAACAAC TCCGCCCCAT TGACGCAAAT GGGCGGTAGG CGTGTACGGT 
1701 GGGAGGTCTA TATAAGCAGA GCTCTCTGGC TAACTAGAGA ACCCACTGCT 
1751 TACTGGCTTA TCGAAATTAA TACGACTCAC TATAGGGAGA CCCAAGCTGG 
1801 CTAGCGTTTA AACTTAAGCT TGGTACCCGG GGATCCTCTA GGGCCTCTGA 
1851 GCTATTCCAG AAGTAGTGAA GAGGCTTTTT TGGAGGCCTA GGCTTTTGCA 
1901 AAAAGCTCCG GATCGATCCT GAGAACTTCA GGGTGAGTTT GGGGACCCTT 
1951 GATTGTTCTT TCTTTTTCGC TATTGTAAAA TTCATGTTAT ATGGAGGGGG 
2001 CAAAGTTTTC AGGGTGTTGT TTAGAATGGG AAGATGTCCC TTGTATCACC 
2051 ATGGACCCTC ATGATAATTT TGTTTCTTTC ACTTTCTACT CTGTTGACAA 
2101 CCATTGTCTC CTCTTATTTT CTTTTCATTT TCTGTAACTT TTTCGTTAAA 
2151 CTTTAGCTTG CATTTGTAAC GAATTTTTAA ATTCACTTTT GTTTATTTGT 
2201 CAGATTGTAA GTACTTTCTC TAATCACTTT TTTTTCAAGG CAATCAGGGT 
100 
 
2251 ATATTATATT GTACTTCAGC ACAGTTTTAG AGAACAATTG TTATAATTAA 
2301 ATGATAAGGT AGAATATTTC TGCATATAAA TTCTGGCTGG CGTGGAAATA 
2351 TTCTTATTGG TAGAAACAAC TACATCCTGG TCATCATCCT GCCTTTCTCT 
2401 TTATGGTTAC AATGATATAC ACTGTTTGAG ATGAGGATAA AATACTCTGA 
2451 GTCCAAACCG GGCCCCTCTG CTAACCATGT TCATGCCTTC TTCTTTTTCC 
2501 TACAGCTCCT GGGCAACGTG CTGGTTATTG TGCTGTCTCA TCATTTTGGC 
2551 AAAGAATTGT AATACGACTC ACTATAGGGC GAATTGATAT GTCTAGATTA 
2601 GATAAAAGTA AAGTGATTAA CAGCGCATTA GAGCTGCTTA ATGAGGTCGG 
2651 AATCGAAGGT TTAACAACCC GTAAACTCGC CCAGAAGCTA GGTGTAGAGC 
2701 AGCCTACATT GTATTGGCAT GTAAAAAATA AGCGGGCTTT GCTCGACGCC 
2751 TTAGCCATTG AGATGTTAGA TAGGCACCAT ACTCACTTTT GCCCTTTAGA 
2801 AGGGGAAAGC TGGCAAGATT TTTTACGTAA TAACGCTAAA AGTTTTAGAT 
2851 GTGCTTTACT AAGTCATCGC GATGGAGCAA AAGTACATTT AGGTACACGG 
2901 CCTACAGAAA AACAGTATGA AACTCTCGAA AATCAATTAG CCTTTTTATG 
2951 CCAACAAGGT TTTTCACTAG AGAATGCATT ATATGCACTC AGCGCTGTGG 
3001 GGCATTTTAC TTTAGGTTGC GTATTGGAAG ATCAAGAGCA TCAAGTCGCT 
3051 AAAGAAGAAA GGGAAACACC TACTACTGAT AGTATGCCGC CATTATTACG 
3101 ACAAGCTATC GAATTATTTG ATCACCAAGG TGCAGAGCCA GCCTTCTTAT 
101 
 
3151 TCGGCCTTGA ATTGATCATA TGCGGATTAG AAAAACAACT TAAATGTGAA 
3201 AGTGGGTCCG CGTACAGCGG ATCCCGGGAA TTCAGATCTT ATTAAAGCAG 
3251 AACTTGTTTA TTGCAGCTTA TAATGGTTAC AAATAAAGCA ATAGCATCAC 
3301 AAATTTCACA AATAAAGCAT TTTTTTCACT GCATTCTAGT TGTGGTTTGT 
3351 CCAAACTCAT CAATGTATCT TATCATGTCT GGTCGAATCC ATCACACTGG 
3401 CGGCCGCTCG AGTCTAGAGG GCCCGCGGTT CGAAGGTAAG CCTATCCCTA 
3451 ACCCTCTCCT CGGTCTCGAT TCTACGCGTG GTGTGGAAAG TCCCCAGGCT 
3501 CCCCAGCAGG CAGAAGTATG CAAAGCATGC ATCTCAATTA GTCAGCAACC 
3551 AGGTGTGGAA AGTCCCCAGG CTCCCCAGCA GGCAGAAGTA TGCAAAGCAT 
3601 GCATCTCAAT TAGTCAGCAA CCATAGTCCC GCCCCTAACT CCGCCCATCC 
3651 CGCCCCTAAC TCCGCCCAGT TCCGCCCATT CTCCGCCCCA TGGCTGACTA 
3701 ATTTTTTTTA TTTATGCAGA GGCCGAGGCC GCCTCGGCCT CTGAGCTATT 
3751 CCAGAAGTAG TGAGGAGGCT TTTTTGGAGG CCTAGTCTCG ATGTTGACAA 
3801 TTAATCATCG GCATAGTATA TCGGCATAGT ATAATACGAC GGATCAAGGA 
3851 GGTCGACCAT GGCCAAGTTG ACCAGTGCCG TTCCGGTGCT CACCGCGCGC 
3901 GACGTCGCCG GAGCGGTCGA GTTCTGGACC GACCGGCTCG GGTTCTCCCG 
3951 GGACTTCGTG GAGGACGACT TCGCCGGTGT GGTCCGGGAC GACGTGACCC 
4001 TGTTCATCAG CGCGGTCCAG GACCAGGTGG TGCCGGACAA CACCCTGGCC 
102 
 
4051 TGGGTGTGGG TGCGCGGCCT GGACGAGCTG TACGCCGAGT GGTCGGAGGT 
4101 CGTGTCCACG AACTTCCGGG ACGCCTCCGG GCCGGCCATG ACCGAGATCG 
4151 GCGAGCAGCC GTGGGGGCGG GAGTTCGCCC TGCGCGACCC GGCCGGCAAC 
4201 TGCGTGCACT TCGTGGCCGA GGAGCAGGAC TGAACTAGCG ATATCACTAG 
4251 GGGGAGGCTA ACTGAAACAC GGAAGGAGAC AATACCGGAA GGAACCCGCG 
4301 CTATGACGGC AATAAAAAGA CAGAATAAAA CGCACGGTGT TGGGTCGTTT 
4351 GTTCATAAAC GCGGGGTTCG GTCCCAGGGC TGGCACTCTG TCGATACCCC 
4401 ACCGAGACCC CATTGGGGCC AATACGCCCG CGTTTCTTCC TTTTCCCCAC 
4451 CCCACCCCCC AAGTTCGGGT GAAGGCCCAG GGCTCGCAGC CAACGTCGGG 
4501 GCGGCAGG                                
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pHIPPY sequence             
      1 CAATTCGCCA GGAACCGTAA AAAGGCCGCG TTGCTGGCGT TTTTCCATAG 
   51 GCTCCGCCCC CCTGACGAGC ATCACAAAAA TCGACGCTCA AGTCAGAGGT 
  101 GGCGAAACCC GACAGGACTA TAAAGATACC AGGCGTTTCC CCCTGGAAGC 
  151 TCCCTCGTGC GCTCTCCTGT TCCGACCCTG CCGCTTACCG GATACCTGTC 
  201 CGCCTTTCTC CCTTCGGGAA GCGTGGCGCT TTCTCATAGC TCACGCTGTA 
  251 GGTATCTCAG TTCGGTGTAG GTCGTTCGCT CCAAGCTGGG CTGTGTGCAC 
  301 GAACCCCCCG TTCAGCCCGA CCGCTGCGCC TTATCCGGTA ACTATCGTCT 
  351 TGAGTCCAAC CCGGTAAGAC ACGACTTATC GCCACTGGCA GCAGCCACTG 
  401 GTAACAGGAT TAGCAGAGCG AGGTATGTAG GCGGTGCTAC AGAGTTCTTG 
  451 AAGTGGTGGC CTAACTACGG CTACACTAGA AGGACAGTAT TTGGTATCTG 
  501 CGCTCTGCTG AAGCCAGTTA CCTTCGGAAA AAGAGTTGGT AGCTCTTGAT 
  551 CCGGCAAACA AACCACCGCT GGTAGCGGTG GTTTTTTTGT TTGCAAGCAG 
  601 CAGATTACGC GCAGAAAAAA AGGATCTCAA GAAGATCCTT TGATCTTTTC 
  651 TACGGGGTCT GACGCTCAGT GGGCGGCCGC ATTTGCATGT CGCTATGTGT 
  701 TCTGGGAAAT CACCATAAAC GTGAAATGTC TTTGGATTTG GGAATCTTAT 
  751 AAGTGGATCC TGAGACCGTC TCAAAAAGCA AGCTGACCCT GAAGTTCATT 
104 
 
  801 TTTTGAGACG CTAGCCACAA GATATATAAA GCCAAGAAAT CGAAATACTT 
  851 TCAAGTTACG GTAAGCATAT GATAGTCCAT TTTAAAACAT AATTTTAAAA 
  901 CTGCAAACTA CCCAAGAAAT TATTACTTTC TACGTCACGT ATTTTGTACT 
  951 AATATCTTTG TGTTTACAGT CAAATTAATT CTAATTATCT CTCTAACAGC 
 1001 CTTGTATCGT ATATGCAAAT ATGAAGGAAT CATGGGAAAT AGGCCCTCTT 
 1051 CCTGCCCGAC CTTGGCGCGC GCTCGGCGCG CGGTCACGCT CCGTCACGTG 
 1101 GTGCGTTTTG CCTGCGCGTC TTTCCACTGG GGACGCGTGG TGTGGAAAGT 
 1151 CCCCAGGCTC CCCAGCAGGC AGAAGTATGC AAAGCATGCA TCTCAATTAG 
 1201 TCAGCAACCA GGTGTGGAAA GTCCCCAGGC TCCCCAGCAG GCAGAAGTAT 
 1251 GCAAAGCATG CATCTCAATT AGTCAGCAAC CATAGTCCCG CCCCTAACTC 
 1301 CGCCCATCCC GCCCCTAACT CCGCCCAGTT CCGCCCATTC TCCGCCCCAT 
 1351 GGCTGACTAA TTTTTTTTAT TTATGCAGAG GCCGAGGCCG CCTCGGCCTC 
 1401 TGAGCTATTC CAGAAGTAGT GAGGAGGCTT TTTTGGAGGC CTAGTCTCGA 
 1451 TGTTGACAAT TAATCATCGG CATAGTATAT CGGCATAGTA TAATACGACG 
 1501 GATCAAGGAG GTCGACCATG GCCAAGTTGA CCAGTGCCGT TCCGGTGCTC 
 1551 ACCGCGCGCG ACGTCGCCGG AGCGGTCGAG TTCTGGACCG ACCGGCTCGG 
 1601 GTTCTCCCGG GACTTCGTGG AGGACGACTT CGCCGGTGTG GTCCGGGACG 
 1651 ACGTGACCCT GTTCATCAGC GCGGTCCAGG ACCAGGTGGT GCCGGACAAC 
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 1701 ACCCTGGCCT GGGTGTGGGT GCGCGGCCTG GACGAGCTGT ACGCCGAGTG 
 1751 GTCGGAGGTC GTGTCCACGA ACTTCCGGGA CGCCTCCGGG CCGGCCATGA 
 1801 CCGAGATCGG CGAGCAGCCG TGGGGGCGGG AGTTCGCCCT GCGCGACCCG 
 1851 GCCGGCAACT GCGTGCACTT CGTGGCCGAG GAGCAGGACT GAACTAGCGA 
 1901 TATCACTAGG GGGAGGCTAA CTGAAACACG GAAGGAGACA ATACCGGAAG 
 1951 GAACCCGCGC TATGACGGCA ATAAAAAGAC AGAATAAAAC GCACGGTGTT 
 2001 GGGTCGTTTG TTCATAAACG CGGGGTTCGG TCCCAGGGCT GGCACTCTGT 
 2051 CGATACCCCA CCGAGACCCC ATTGGGGCCA ATACGCCCGC GTTTCTTCCT 
 2101 TTTCCCCACC CCACCCCCCA AGTTCGGGTG AAGGCCCAGG GCTCGCAGCC 
 2151 AACGTCGGGG CGGCAGG   
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